Synthetic data in machine learning for medicine and healthcare

Richard J Chen; Ming Y Lu; Tiffany Y Chen; Drew F K Williamson; Faisal Mahmood

doi:10.1038/s41551-021-00751-8

Synthetic data in machine learning for medicine and healthcare

Nat Biomed Eng. 2021 Jun;5(6):493-497. doi: 10.1038/s41551-021-00751-8.

Authors

Richard J Chen^{1

2

3

4}, Ming Y Lu^{1

3

4}, Tiffany Y Chen^{1

3}, Drew F K Williamson^{1

3}, Faisal Mahmood^{5

6

7}

Affiliations

¹ Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
² Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
³ Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.
⁴ Cancer Data Science Program, Dana-Farber Cancer Institute, Boston, MA, USA.
⁵ Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. faisalmahmood@bwh.harvard.edu.
⁶ Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA. faisalmahmood@bwh.harvard.edu.
⁷ Cancer Data Science Program, Dana-Farber Cancer Institute, Boston, MA, USA. faisalmahmood@bwh.harvard.edu.

Abstract

The proliferation of synthetic data in artificial intelligence for medicine and healthcare raises concerns about the vulnerabilities of the software and the challenges of current policy.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Carcinoma, Renal Cell / diagnostic imaging
Carcinoma, Renal Cell / pathology
Datasets as Topic
Delivery of Health Care / organization & administration*
Diagnosis, Computer-Assisted / methods*
Diagnostic Imaging
Humans
Image Interpretation, Computer-Assisted / statistics & numerical data
Information Theory
Kidney Neoplasms / diagnostic imaging
Kidney Neoplasms / pathology
Machine Learning / standards
Machine Learning / supply & distribution*
Quality Control
Synthetic Biology / instrumentation
Synthetic Biology / methods*

Abstract

Publication types

MeSH terms

Grants and funding